The J&J vaccine use was restarted. Should you be concerned about blood clots and low platelets?
The Johnson and Johnson COVID-19 vaccine is considered safe although There is an extremely rare risk of thrombosis thrombocytopenia syndrome (TTS) among women younger than the age of 50. The benefits from the Johnson and Johnson vaccine shot outweigh the risk of blood clot. However, if you develop Severe headache, chest pain, trouble breathing, extremity pain etc. five days to two weeks after receiving the jnj vaccine, you should contact your physician as soon as possible.
It is important to remember that we are still in the middle of the COVID-19 pandemic, Without Covid vaccination, the risks of getting Covid infection is quite high.
In fact, the COVID-19 infection carries a much higher risk of blood clots . Studies have demonstrated that about 1 out 7 hospitalized COVID-19 patients experienced some type of blood clot.
If you still have concerns about the rare risk of blood clot and low platelets associated with the Johnson and Johnson covid vaccine, you may consider getting the mRNA covid vaccines from Pfizer or moderna. So far there is no report of TTS from getting these 2 mRNA vaccines.